FOXP3+ T Regulatory Cell Modifications in Inflammatory Bowel Disease Patients Treated with Anti-TNF Agents
Figure 4
(a) Correlation between age of IBD patients and delta Treg frequencies between T1 and T0 (Spearman’s rho = −0.49; ; ). (b) Correlation between disease duration in months and delta Treg level between T1 and T0 (Spearman’s rho = −0.36; ; ). (c) Correlation between delta CDAI and delta Treg level between T1 and T0 in Crohn’s disease patients (Spearman’s rho = −0.58; ; ).